-transparent.png){kind=logo}
Sodium N-benzyl-D-glucamine dithiocarbamate (BGD) was evaluated for its efficacy as an inhibitor of cis-diamminedichloroplatinum (DDP)-induced nephrotoxicity in a rat model. Treatment with 2.0 mmol/kg of BGD immediately after DDP injection effectively prevented nephrotoxic effects of DDP, but administration of BGD -1 or 1 h after DDP afforded a small protection. Concurrent treatment with 0.5 mmol/kg of BGD could not prevent renal damage. The platinum concentrations in liver and kidney were significantly decreased by BGD treatment. The antitumor efficacy of DDP in the Walker 256 carcinoma-bearing rats was not affected by administration of BGD (2.0 mmol/kg).
Related Publications
M Kiyozumi, and
T Inoue, and
S Kojima, and
S Hidaka, and
M Tsuruoka
September 1995,
Renal failure,
M Kiyozumi, and
T Inoue, and
S Kojima, and
S Hidaka, and
M Tsuruoka
January 1995,
Journal of applied toxicology : JAT,
M Kiyozumi, and
T Inoue, and
S Kojima, and
S Hidaka, and
M Tsuruoka
March 1993,
Biological & pharmaceutical bulletin,
M Kiyozumi, and
T Inoue, and
S Kojima, and
S Hidaka, and
M Tsuruoka
November 1999,
Renal failure,
M Kiyozumi, and
T Inoue, and
S Kojima, and
S Hidaka, and
M Tsuruoka
January 1990,
Archives of toxicology,
M Kiyozumi, and
T Inoue, and
S Kojima, and
S Hidaka, and
M Tsuruoka
June 1989,
Cancer research,
M Kiyozumi, and
T Inoue, and
S Kojima, and
S Hidaka, and
M Tsuruoka
May 1990,
Chemical & pharmaceutical bulletin,
M Kiyozumi, and
T Inoue, and
S Kojima, and
S Hidaka, and
M Tsuruoka
July 1987,
Toxicology,
M Kiyozumi, and
T Inoue, and
S Kojima, and
S Hidaka, and
M Tsuruoka
January 2005,
Toxicology and applied pharmacology,
M Kiyozumi, and
T Inoue, and
S Kojima, and
S Hidaka, and
M Tsuruoka
February 1990,
Research communications in chemical pathology and pharmacology,
